Department of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.; Department of Orthopaedic Sports Medicine, Technical University, Munich, Germany.
Department of Orthopaedic Surgery, University of Connecticut, Farmington, Connecticut, U.S.A.; Department of Orthopaedic Sports Medicine, Technical University, Munich, Germany.
Arthroscopy. 2021 Jul;37(7):2043-2052. doi: 10.1016/j.arthro.2021.01.064. Epub 2021 Feb 11.
To evaluate whether nucleated cell count (NCC) could serve as an approximation for the number of colony-forming units (CFUs) in concentrated bone marrow aspirate (cBMA) obtained from the proximal humerus.
Bone marrow aspirate (BMA) was harvested from the proximal humerus in 96 patients (mean age 56.2 ± 7.0 years) during arthroscopic rotator cuff repair. Following concentration of the aspirate, nucleated cells of each sample were counted. The total number of CFUs was evaluated under the microscope at their first appearance, usually after 5 to 10 days in culture. Fluorescence-activated cell sorting analysis and assays for osteogenic, adipogenic, and chondrogenic differentiation were performed. Linear regression was assessed to predict the number of CFUs by using NCC. Age, sex, and body mass index (BMI) were evaluated as independent variables.
The average volume of the obtained BMA was 86.7 ± 35.2 mL. The cBMA contained a mean of 26.3 ± 6.8 × 10 nucleated cells per mL, which yielded a mean of 1421.7 ± 802.7 CFUs in cell culture. There were no significant differences in NCC or number of CFUs when sex, volume of BMA, age, or BMI was examined independently (P >.05, respectively). Linear regression found that NCC was of limited predictive value for the total number of CFUs being yielded after cell culture (r = 0.28 with a root mean square error of 679.4).
NCC was of negligible predictive value for the total number of CFUs for connective tissue progenitor cells in BMA harvested from the proximal humerus during arthroscopic rotator cuff repair.
NCC is often used to assess the quality of cBMA samples for biological augmentation during surgery. The limited predictive value of this measurement tool is of clinical importance, because effectiveness of BMA applications has been suggested to depend on the concentration of progenitor cells within the sample.
评估核细胞计数(NCC)是否可作为关节镜肩袖修复时从肱骨头近端抽吸的浓缩骨髓抽吸物(cBMA)中集落形成单位(CFU)数量的近似值。
在 96 例(平均年龄 56.2±7.0 岁)关节镜肩袖修复患者中,从肱骨头近端采集骨髓抽吸物(BMA)。抽吸物浓缩后,对每个样本的核细胞进行计数。在培养 5 至 10 天后,通常在显微镜下评估总 CFU 数。进行荧光激活细胞分选分析以及成骨、成脂和软骨分化的测定。通过 NCC 评估线性回归来预测 CFU 数。评估年龄、性别和体重指数(BMI)作为自变量。
获得的 BMA 平均体积为 86.7±35.2mL。cBMA 中平均每毫升含有 26.3±6.8×10 个核细胞,在细胞培养中平均产生 1421.7±802.7CFU。当分别检查性别、BMA 体积、年龄或 BMI 时,NCC 或 CFU 数量没有显着差异(分别为 P>.05)。线性回归发现,NCC 对细胞培养后产生的总 CFU 数的预测值有限(r=0.28,均方根误差为 679.4)。
NCC 对关节镜肩袖修复时从肱骨头近端抽吸的 BMA 中结缔组织祖细胞的总 CFU 数的预测价值可以忽略不计。
NCC 常用于评估手术中生物增强时 cBMA 样本的质量。该测量工具的预测值有限具有临床重要意义,因为 BMA 应用的有效性已被认为取决于样本中祖细胞的浓度。